<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0372763</journal-id>
<journal-id journal-id-type="nlm-ta">Diabetes</journal-id>
<journal-id journal-id-type="iso-abbrev">Diabetes</journal-id>
<journal-title-group>
<journal-title>Diabetes</journal-title>
</journal-title-group>
<issn pub-type="ppub">0012-1797</issn>
<issn pub-type="epub">1939-327X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28115397</article-id>
<article-id pub-id-type="pmc">7360433</article-id>
<article-id pub-id-type="manuscript">EMS71250</article-id>
<article-id pub-id-type="doi">10.2337/db16-0336</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of α<sub>2</sub>δ-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mastrolia</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Flucher</surname>
<given-names>Sylvia M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Obermair</surname>
<given-names>Gerald J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drach</surname>
<given-names>Mathias</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hofer</surname>
<given-names>Helene</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Renström</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwartz</surname>
<given-names>Arnold</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Striessnig</surname>
<given-names>Jörg</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Flucher</surname>
<given-names>Bernhard E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tuluc</surname>
<given-names>Petronel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Physiology and Medical Physics, Medical University Innsbruck, Innsbruck, Austria</aff>
<aff id="A2">
<label>2</label>Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria</aff>
<aff id="A3">
<label>3</label>Department of General Pathology, Medical University Innsbruck, Innsbruck, Austria</aff>
<aff id="A4">
<label>4</label>Department of Clinical Sciences Malmö, Lund University, Lund, Sweden</aff>
<aff id="A5">
<label>5</label>College of Medicine, University of Cincinnati, Cincinnati, OH</aff>
<author-notes>
<corresp id="CR1">Corresponding authors: Petronel Tuluc, <email>petronel.tuluc@uibk.ac.at</email>, and Bernhard E. Flucher, <email>bernhard.e.flucher@i-med.ac.at.</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P34"><bold>Duality of Interest.</bold> No potential conflicts of interest relevant to this article were reported.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>31</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>66</volume>
<issue>4</issue>
<fpage>897</fpage>
<lpage>907</lpage>
<!--elocation-id from pubmed: 10.2337/db16-0336-->
<permissions>
<license license-type="open-access" xlink:href="http://www.diabetesjournals.org/content/license">
<license-p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at <ext-link ext-link-type="uri" xlink:href="http://www.diabetesjournals.org/content/license">http://www.diabetesjournals.org/content/license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Reduced pancreatic β-cell function or mass is the critical problem in developing diabetes. Insulin release from β-cells depends on Ca<sup>2+</sup> influx through high voltage– gated Ca<sup>2+</sup> channels (HVCCs). Ca<sup>2+</sup> influx also regulates insulin synthesis and insulin granule priming and contributes to β-cell electrical activity. The HVCCs are multisubunit protein complexes composed of a pore-forming α1 and auxiliary β and α<sub>2</sub>δ subunits. α<sub>2</sub>δ is a key regulator of membrane incorporation and function of HVCCs. Here we show that genetic deletion of α<sub>2</sub>δ-1, the dominant α<sub>2</sub>δ subunit in pancreatic islets, results in glucose intolerance and diabetes without affecting insulin sensitivity. Lack of the α<sub>2</sub>δ-1 subunit reduces the Ca<sup>2+</sup> currents through all HVCC isoforms expressed in β-cells equally in male and female mice. The reduced Ca<sup>2+</sup> influx alters the kinetics and amplitude of the global Ca<sup>2+</sup> response to glucose in pancreatic islets and significantly reduces insulin release in both sexes. The progression of diabetes in males is aggravated by a selective loss of β-cell mass, while a stronger basal insulin release alleviates the diabetes symptoms in most α<sub>2</sub>δ-1<sup>−/−</sup> female mice. Together, these findings demonstrate that the loss of the Ca<sup>2+</sup> channel α<sub>2</sub>δ-1 subunit function increases the susceptibility for developing diabetes in a sex-dependent manner.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>